U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry EPIMERIC
Molecular Formula C8H11NO2.C4H6O6
Molecular Weight 303.2653
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OCTOPAMINE TARTRATE

SMILES

O[C@H]([C@@H](O)C(O)=O)C(O)=O.NCC(O)C1=CC=C(O)C=C1

InChI

InChIKey=SEYAYFMQVRHSQR-LREBCSMRSA-N
InChI=1S/C8H11NO2.C4H6O6/c9-5-8(11)6-1-3-7(10)4-2-6;5-1(3(7)8)2(6)4(9)10/h1-4,8,10-11H,5,9H2;1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1

HIDE SMILES / InChI

Molecular Formula C8H11NO2
Molecular Weight 153.1784
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula C4H6O6
Molecular Weight 150.0868
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Octopamine is an organic chemical closely related to norepinephrine. In many types of invertebrates it functions as a neurotransmitter. Octopamine is known to exert adrenergic effects in mammals although specific octopamine receptors have been cloned only in invertebrates. It has been shown that octopamine can stimulate alpha(2)-adrenoceptors (ARs) in Chinese hamster ovary cells transfected with human alpha(2)-ARs. Octopamine stimulates lipolysis through beta(3)-rather than beta(1)-or beta(2)-AR activation in white adipocytes from different mammalian species. Octopamine activates only beta(3)-ARs and is devoid of alpha(2)-adrenergic agonism. Thus, octopamine could be considered as an endogenous selective beta(3)-AR agonist. In humans Octopamine is a trace amine found endogenously in the human brain where it interacts with signalling of catecholamines; it is structurally similar to synephrine and tyramine, being a metabolite of the latter (via dopamine β-hydroxylase) and substrate for the synthesis of the former (via phenethanolamine N-methyltransferase[3]) while being perhaps the closest in structure to noradrenaline. Octopamine is found in the bitter orange similar to many biogenic amines related to L-tyrosine that are used as dietary supplements, this includes synephrine and hordenine. p-Octopamine HCl (Norphen) was studied in the late 1960’s and 1970’s as a drug for the treatment of hypotensive regulatory and circulatory disorders. Octopamine was used as a nootropic. All optical isomers (enantiomers) of octopamine are on the World Anti-Doping Agency (WADA) 2014 list of substances prohibited in competition.

CNS Activity

Curator's Comment: Octopamine (OA), a biogenic monoamine structurally related to noradrenaline, acts as a neurohormone, a neuromodulator and a neurotransmitter in invertebrates. The known actions of OA in the central nervous system include desensitization of sensory inputs, influence on learning and memory, or regulation of the 'mood' of the animal. In vertebrates p-Octopamine is considered to be a CNS stimulant in spite of the fact that it binds poorly to adrenergic receptors.

Approval Year

Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
39.1 ng/mL
2 mg single, intravenous
dose: 2 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
OCTOPAMINE serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
213 ng/mL
8 mg single, oral
dose: 8 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
OCTOPAMINE serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
243 min
2 mg single, intravenous
dose: 2 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
OCTOPAMINE serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
175 min
8 mg single, oral
dose: 8 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
OCTOPAMINE serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
67%
OCTOPAMINE serum
Homo sapiens
Overview

Overview

OverviewOther

Drug as perpetrator​

Drug as perpetrator​

TargetModalityActivityMetaboliteClinical evidence
inconclusive [IC50 0.1096 uM]
inconclusive
no
no
no
no
yes [Inhibition 10 uM]
yes [Inhibition 10 uM]
Drug as victimTox targets

Tox targets

TargetModalityActivityMetaboliteClinical evidence
PubMed

PubMed

TitleDatePubMed
Molecular and functional characterization of an octopamine receptor from honeybee (Apis mellifera) brain.
2003-08
HPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytes.
2003-07-31
Octopaminergic modulation of synaptic transmission between an identified sensory afferent and flight motoneuron in the locust.
2003-07-14
Presynaptic impairment of synaptic transmission in Drosophila embryos lacking Gs(alpha).
2003-07-02
The control of vascular resistance in the southern rock lobster, Jasus edwardsii (Decapoda: Palinuridae).
2003-07
Modulation of early olfactory processing by an octopaminergic reinforcement pathway in the honeybee.
2003-06-15
Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase.
2003-06
To swim or not to swim: regional effects of serotonin, octopamine and amine mixtures in the medicinal leech.
2003-06
B96Bom encodes a Bombyx mori tyramine receptor negatively coupled to adenylate cyclase.
2003-06
Hygienic behavior in the honey bee (Apis mellifera L.) and the modulatory role of octopamine.
2003-06
Elusive amines and primary headaches: historical background and prospectives.
2003-05
Metabolic flux analysis of the phenylpropanoid pathway in wound-healing potato tuber tissue using stable isotope-labeled tracer and LC-MS spectroscopy.
2003-05
Synaptic facilitation by ectopic octopamine and 5-HT receptors in Aplysia.
2003-04-15
The effect of octopamine on behavioral responses of free-foraging bumblebees to a change in food source profitability.
2003-04
Agonist-specific coupling of a cloned human alpha1A-adrenoceptor to different second messenger pathways.
2003-04
Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor-masked hypovolemia.
2003-03
Central modulatory neurons control fuel selection in flight muscle of migratory locust.
2003-02-15
Biogenic amines in the antennal lobes and the initiation and maintenance of foraging behavior in honey bees.
2003-02-05
Octopamine modulates spermathecal muscle contractions in Locusta migratoria.
2003-02
Functionally distinct dopamine and octopamine transporters in the CNS of the cabbage looper moth.
2003-02
Site-directed mutagenesis studies on the Drosophila octopamine/tyramine receptor.
2003-02
Neurohormonal and glutamatergic neuronal control of the cardioarterial valves in the isopod crustacean Bathynomus doederleini.
2003-02
Three-dimensional pharmacophore hypotheses of octopamine/tyramine agonists which inhibit [1-14C]acetate incorporation in Plodia interpunctella.
2003-01-02
Positive and negative modulation of Bombyx mori adenylate cyclase by 5-phenyloxazoles: identification of octopamine and tyramine receptor agonists.
2003-01
Serotonin regulates repolarization of the C. elegans pharyngeal muscle.
2003-01
Unusual genetic architecture of natural variation affecting drug resistance in Drosophila melanogaster.
2002-12
Behavioural pharmacology of octopamine, tyramine and dopamine in honey bees.
2002-11-15
Immunoreactivity against choline acetyltransferase, gamma-aminobutyric acid, histamine, octopamine, and serotonin in the larval chemosensory system of Dosophila melanogaster.
2002-11-11
Serotonin precursor (5-hydroxytryptophan) has a profound effect on the post-copulatory time-fixed sexually refractory stage in the male cricket, Gryllus bimaculatus DeGeer.
2002-11
Three-dimensional common-feature hypotheses of inhibitors of calling behaviour and in vitro [14C]acetate incorporation by pheromone glands of Plodia interpunctella.
2002-11
Activation of octopaminergic receptors by essential oil constituents isolated from aromatic plants: possible mode of action against insect pests.
2002-11
Biogenic amines evoke heartbeat reversal in larvae of the sweet potato hornworm, Agrius convolvuli.
2002-11
Central regulation of photosensitive membrane turnover in the lateral eye of Limulus. I. Octopamine primes the retina for daily transient rhabdom shedding.
2002-10-24
Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands.
2002-10-17
Three-dimensional common-feature hypotheses for octopamine agonist arylethanolamines.
2002-10
Stress response in Drosophila melanogaster strain inactive with decreased tyramine and octopamine contents.
2002-10
A trace amine, tyramine, functions as a neuromodulator in Drosophila melanogaster.
2002-09-06
Juvenile hormone and octopamine in the regulation of division of labor in honey bee colonies.
2002-09
Octopamine enhances moth olfactory responses to pheromones, but not those to general odorants.
2002-09
Octopamine modulates responsiveness to foraging-related stimuli in honey bees (Apis mellifera).
2002-09
Characterization of a tyramine receptor from Caenorhabditis elegans.
2002-09
Determination of adrenergic agonists from extracts and herbal products of Citrus aurantium L. var. amara by LC.
2002-08-01
Ingestion of double-stranded RNA by preparasitic juvenile cyst nematodes leads to RNA interference.
2002-08
Intracerebroventricular administration of octopamine stimulates food intake of chicks through alpha(2)-adrenoceptor.
2002-08
Neurochemical fine tuning of a peripheral tissue: peptidergic and aminergic regulation of fluid secretion by Malpighian tubules in the tobacco hawkmoth M. sexta.
2002-07
Are monoaminergic systems involved in the lethargy induced by a parasitoid wasp in the cockroach prey?
2002-05
Modulating the modulators: parasites, neuromodulators and host behavioral change.
2002
A role for octopamine in honey bee division of labor.
2002
Metamodulation of the biogenic amines: second-order modulation by steroid hormones and amine cocktails.
2002
Heterosynaptic modulation by the octopaminergic OC interneurons increases the synaptic outputs of protraction phase interneurons (SO, N1L) in the feeding system of Lymnaea stagnalis.
2002
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Also was used orally In a study using a 150 mg octopamine sustained release tablet to treat hypotension, the author recommended one or two tablets before arising, and another tablet at night as needed (Stucke, 1972). In a similar study (Braasch et al., 1971), subjects received the octopamine sustained release tablet three times daily. In both cases under the described conditions, the product was reported to raise systolic blood pressure by approximately 6 to14 mm Hg.
When 500 mg p-octopamine was infused intravenously over 30–40 minutes into human subjects, systolic blood pressure increases of about 15 mm Hg were observed within 10 minutes. Intramuscular administration of 50 mg of a depo (slow release) form of p-octopamine into humans resulted in similar increases in systolic blood pressure.
Route of Administration: Other
In isolated adipocytes from rats, the concentrations of 0.01– 0.10 nmol p-octopamine activated b-3 adrenergic receptors to lower glucose uptake into adipocytes and increase cAMP.
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:38:54 GMT 2025
Edited
by admin
on Mon Mar 31 22:38:54 GMT 2025
Record UNII
5GQV08V31D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OCTOPAMINE HYDROGEN TARTRATE
Preferred Name English
OCTOPAMINE TARTRATE
Common Name English
BENZYL ALCOHOL, .ALPHA.-(AMINOMETHYL)-P-HYDROXY-, TARTRATE (1:1)
Systematic Name English
BENZENEMETHANOL, .ALPHA.-(AMINOMETHYL)-4-HYDROXY-, (2R,3R)-2,3-DIHYDROXYBUTANEDIOATE (1:1) (SALT)
Systematic Name English
Code System Code Type Description
CAS
81098-58-0
Created by admin on Mon Mar 31 22:38:54 GMT 2025 , Edited by admin on Mon Mar 31 22:38:54 GMT 2025
PRIMARY
FDA UNII
5GQV08V31D
Created by admin on Mon Mar 31 22:38:54 GMT 2025 , Edited by admin on Mon Mar 31 22:38:54 GMT 2025
PRIMARY
PUBCHEM
44151651
Created by admin on Mon Mar 31 22:38:54 GMT 2025 , Edited by admin on Mon Mar 31 22:38:54 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY